ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03769
-0,42%
Bitcoin
102.228,93
0,20%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Allergy Therapeutics Plc (AGY) Börsenkurse

Allergy Therapeutics Plc

Allergy Therapeutics Plc (AGY)

Argosy Minerals Inc
7,70
0,00
(0,00%)
Geschlossen 21 Januar 5:30PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
7,70
Gebot
7,00
Fragen
8,00
Volumen
0,00
0,00 Tagesbereich 0,00
1,88 52-Wochen-Bereich 7,71
Marktkapitalisierung
367,016M
Handelsende
7,70
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
519.198
Ausgegebene Aktien
4.766.439.938
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-8,93
Gewinn pro Aktie (EPS)
-0,01
Erlöse
55,2M
Nettogewinn
-40,22M

Über Allergy Therapeutics Plc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.allergytherapeutics.com
Hauptsitz
West Sussex, Gbr
Gegründet
-
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker AGY. The last closing price for Allergy Therapeutics was 7,70p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 1,88p to 7,71p.

Allergy Therapeutics currently has 4.766.439.938 shares in issue. The market capitalisation of Allergy Therapeutics is £367,02 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -8.93.

AGY Neueste Nachrichten

Weitere Nachrichten

Allergy Therapeutics PLC Director/PDMR Shareholding

Allergy Therapeutics PLC 15 January 2025     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   PDMR Dealings   Issue of 687,500,000 Warrants     15 January 2025 - Allergy...

15 Januar 2025
RNS Regulatory News

Allergy Therapeutics PLC Exercise of Options and Total Voting Rights

Allergy Therapeutics PLC 19 December 2024       Allergy Therapeutics plc   ("Allergy Therapeutics", or the "Group")   Exercise of Options and Total Voting Rights   19 December 2024 Allergy...

19 Dezember 2024
RNS Regulatory News

Allergy Therapeutics PLC Block Listing Interim Review

Allergy Therapeutics PLC 17 December 2024   Allergy Therapeutics plc   ("Allergy Therapeutics", "ATL" or the "Group")   Block Listing Interim Review     Name of applicant: ALLERGY THERAPEUTICS...

17 Dezember 2024
RNS Regulatory News

Allergy Therapeutics PLC Result of Annual General Meeting

Allergy Therapeutics PLC 16 December 2024     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group")   Result of Annual General Meeting     16 December 2024 Allergy Therapeutics plc...

16 Dezember 2024
RNS Regulatory News

Allergy Therapeutics PLC Positive Interim Data from PROTECT Trial

Allergy Therapeutics PLC 04 December 2024   Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group")   Allergy Therapeutics announces positive interim analysis data from the...

04 Dezember 2024
RNS Regulatory News

IN BRIEF: Allergy Therapeutics treats first patient in allergy trial

ics PLC - Sussex, England-based biotechnology company - Treats its first patient in the third phase of its paediatric ...

27 November 2024
Alliance News

Allergy Therapeutics PLC First Patient Dosed in G308 Paediatric Trial

Allergy Therapeutics PLC 27 November 2024     Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group")   Allergy Therapeutics announces first patient treated in G308 Phase III...

27 November 2024
RNS Regulatory News

Allergy Therapeutics PLC Submission of MAA for Grass MATA MPL

Allergy Therapeutics PLC 25 November 2024   Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group")   Allergy Therapeutics Submits Marketing Authorisation Application for Grass MATA...

25 November 2024
RNS Regulatory News

Allergy Therapeutics PLC Notice of 2024 Annual General Meeting

Allergy Therapeutics PLC 21 November 2024   Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Notice of 2024 Annual General Meeting     21 November 2024 - Allergy...

21 November 2024
RNS Regulatory News

Allergy Therapeutics annual loss narrows thanks to reduced expenses

Allergy Therapeutics PLC on Wednesday said it narrowed its loss during its most recent financial year despite a decli ...

06 November 2024
Alliance News
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.456.206896551727.257.717.255358757.57439372DE
41.4523.26.257.716.246163427.19205039DE
122.75457.714.855191986.23734549DE
262.2541.28440366975.457.713.884162315.54051292DE
525.1196.1538461542.67.711.885963774.31310969DE
156-17.8-69.803921568625.526.750.855103843.80117355DE
260-3.65-32.158590308411.35400.854451269.04309241DE

AGY - Frequently Asked Questions (FAQ)

What is the current Allergy Therapeutics share price?
The current share price of Allergy Therapeutics is 7,70p
How many Allergy Therapeutics shares are in issue?
Allergy Therapeutics has 4.766.439.938 shares in issue
What is the market cap of Allergy Therapeutics?
The market capitalisation of Allergy Therapeutics is GBP 367,02M
What is the 1 year trading range for Allergy Therapeutics share price?
Allergy Therapeutics has traded in the range of 1,88p to 7,71p during the past year
What is the PE ratio of Allergy Therapeutics?
The price to earnings ratio of Allergy Therapeutics is -8,93
What is the cash to sales ratio of Allergy Therapeutics?
The cash to sales ratio of Allergy Therapeutics is 6,47
What is the reporting currency for Allergy Therapeutics?
Allergy Therapeutics reports financial results in GBP
What is the latest annual turnover for Allergy Therapeutics?
The latest annual turnover of Allergy Therapeutics is GBP 55,2M
What is the latest annual profit for Allergy Therapeutics?
The latest annual profit of Allergy Therapeutics is GBP -40,22M
What is the registered address of Allergy Therapeutics?
The registered address for Allergy Therapeutics is DOMINION WAY, WORTHING, WEST SUSSEX, BN14 8SA
What is the Allergy Therapeutics website address?
The website address for Allergy Therapeutics is www.allergytherapeutics.com
Which industry sector does Allergy Therapeutics operate in?
Allergy Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
0A2IH World Group Ltd
US$ 0,00
(0,00%)
0
0A2DCrh Plc
US$ 0,00
(0,00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0,00
(0,00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0,00
(0,00%)
9
0A1UUber Technologies Inc
US$ 68,55
(0,00%)
86
0A2IH World Group Ltd
US$ 0,00
(0,00%)
0
0A2DCrh Plc
US$ 0,00
(0,00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0,00
(0,00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0,00
(0,00%)
9
0A1UUber Technologies Inc
US$ 68,55
(0,00%)
86
0R0XTesla Inc
US$ 436,80
(0,00%)
24,2k
0R2VApple Inc
US$ 231,00
(0,00%)
23,52k
0R24Intel Corp
US$ 22,16
(0,00%)
22,85k
0XWGIqiyi Inc
US$ 12,70
(0,00%)
7,82k
0R1MExxon Mobil Corp
US$ 113,20
(0,00%)
5,84k

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
AGY
Allergy Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten